Alibasa, Hanina .
HRN: 28-12-90 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
CO-AMOXICLAV 625MG (TAB)
03/20/2026
03/26/2026
ORAL
625mg
BID
UTI
Checking Initial Appropriateness
03/20/2026
CO-AMOXICLAV 625MG (TAB)
03/20/2026
03/26/2026
ORAL
625mg
BID
UTI
Checking Initial Appropriateness